Evaluation of irbesartan effects as a function of the time of drug administration.
Ruiz-Vega
Humberto
H
Facultad de Medicina Dr. Ignacio Chávez, Escuela de Ciencias Fisico-Matemáticas Mat. Luis Manuel Rivera Gutiérrez, Universidad Michoacana de San Nicolás de Hidalgo, Morelia, Michoacán. hrvega@zeus.umich.mx
Vargas-Espinoza
J Manuel
JM
Huape-Arreola
M Sandra
MS
D000328:Adult; D057911:Angiotensin Receptor Antagonists; D000959:Antihypertensive Agents / Q000008:administration & dosage* / Q000494:pharmacology*; D019540:Area Under Curve; D001713:Biphenyl Compounds / Q000008:administration & dosage* / Q000494:pharmacology*; D001794:Blood Pressure / Q000187:drug effects; D005260:Female; D006801:Humans; D000077405:Irbesartan; D008297:Male; D008875:Middle Aged; D013777:Tetrazoles / Q000008:administration & dosage* / Q000494:pharmacology*
D057911:Angiotensin Receptor Antagonists; D000959:Antihypertensive Agents; D001713:Biphenyl Compounds; D013777:Tetrazoles; D000077405:Irbesartan